![closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons](../news/img/healthcare/closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons.jpg)
SMTI announced very solid Revenue growth of 107.811 % year on year to $
13.04 millions in the July to September 30 2022 span, but Losses have extended at $-0.18.
relative to the previous financial reporting period EPS improved from $-0.42 per share and Revenues surged by 34.886 % from $9.67 millions.
For the financial time-frame ending September 30 2022 Sanara Medtech Inc realized net deficit of $-1.412 million, higher than $-1.206 million a year ago.
Sanara Medtech Inc is expected to report next financial results on March 29, 2023.